Chemoprophylaxis in Asthma

References

• Cox J SC. Disodium cromoglycate (FPL 670) “Intal”: A specific inhibitor of reaginic antigen mechanism. Nature 1967; 216: 1328, 1329
   PubMed Web of Science ®Google Scholar
• Altounyan R EC. Inhibitor of experimental asthma by a new compound, disodium cromoglycate “Intal.”. Acta Allergologica 1967; 22: 487, 490
   Google Scholar
• Asthma, Physiology, Immunopharmacology and Treatment: Disodium Cromoglycate in Clinical and Experimental Asthma, K F Austen, L M Lichtenstein. Academic Press, New York 1973; 279–294
   Google Scholar
• Altounyan R EC. Review of clinical activity and mode of action of sodium cromoglycate. Clin Allergy 1989; 10: 481, 489
   Google Scholar
• Morley J. Platelet activation factor and asthma. Agents Actions 1986; 29: 100, 108
   Google Scholar
• Herxheimer H. The late bronchial reaction in induced asthma. Int Arch Allergy 1952; 3: 323, 328
   Web of Science ®Google Scholar
• Altounyan R EC. Changes in histamine and atropine resonsiveness as a guide to diagnostic and evaluation of therapy in obstructive airways disease. Disodium Cromoglycate in Allergic Airways Disease, J. Pepy's, A W. Frankland, London 1970; 47–53
   Google Scholar
• Cockcroft D W., Ruffin R E., Dolovich J, Hargreave F E. Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy 1977; 7: 503, 513
   PubMedGoogle Scholar
• Hill D J. Inter-relation of immediate and late asthmatic reactions in childhood. Allergy 1981; 36: 549, 554
   PubMed Web of Science ®Google Scholar
• Carrol M P., Durham S R., Walsh G, Kay A B. Activation of neutrophils and monocytes after allergen histamine-induced bronchoconstriction. J Allergy Clin Immunol 1985; 75: 290, 296
   PubMed Web of Science ®Google Scholar
• Morley J, Sanjar S, Page C P. The platelet in asthma. Lancet 1984; 2: 1142, 1144
   PubMed Web of Science ®Google Scholar
• Stokes T C., Morley J. Prospects for an oral Intal. Br J Dis Chest 1981; 75: 1, 14
   PubMedGoogle Scholar
• Bernstein I L. Asthma in adults. Allergy: Principle and Practice, E Middelton, Jr, C E Reed, E F Ellis. CV Mosby Co., St Louis 1978; 743
   Google Scholar
• Interhospital Respiratory Disease Committee of Toronto. Standardization of resting respiratory function studies. Ontario Thoracic Society 1979
   Google Scholar
• MacDonald G F., Plumley D L., Korbic R T. Normalization of pulmonary function in bronchial asthma in response to ketotifen prophylaxis: A Three Year Study. Immunol Allergy Prac 1986; 8: 22
   Google Scholar
• Foreman J C., Mongar J L., Gompurts B D., Garland L G. A possible role for cyclic AMP in the regulation of histamine secretion and action of cromoglycate. Biochem Pharmacol 1975; 24: 538, 542
   PubMed Web of Science ®Google Scholar
• Harris M G., Parkes P EG, Lessof M H. Role of bronchial irritant receptors in asthma. Lancet 1981; 15–7
   PubMed Web of Science ®Google Scholar
• Mark M. Cromolyn sodium as primary therapy for pediatric asthma. Am J Asthma Allergy Pediatricians 1988; 1(4)
   Google Scholar
• Petty T L., Rollins R, Christopher K, Good J T., Oakley R. Cromolyn sodium is effective in adult chronic asthmatics. Am Rev Respir Dis 1989; 139: 694, 701
   PubMed Web of Science ®Google Scholar
• MacDonald G F., Kennedy D J. Clinical trial - sodium cromoglycate (SCG) solution. J Can Soc Respir Tech 1980; 16: 18, 22
   Google Scholar
• Martin U, Romer D. The pharmacological properties of a new orally active antianaphylactic compound: Ketotifen a benzocycloheptathiophene. Arzneim Forsch/Drug Res 1979; 28: 770, 782
   Web of Science ®Google Scholar
• Martin U, Greenwood C, Craps L, Baggiolini M. Ketotifen in Pharmacological and Biochemical Properties of Drug Substances, Goldberg ME. Academy of Pharmaceutical Sciences, Washington, DC 1981; Vol. 3: 424
   Google Scholar
• MacDonald G F. An overview of ketotifen. Chest, 825: 305, 325, 1892
   Google Scholar
• Klein G, Urbanek R, Matthys H, Hamm M. Protective effect of ketotifen and disodium cromoglycate in bronchial challenge test with allergens. Dtsch Med Wschr 1980; 10: 519, 525
   Google Scholar
• Neijens H J., Knol K. A multicenter study on the efficacy of ketotifen in wheezy infants. Triangle 1987; 26: 29–34, (Suppl)
   Google Scholar
• Dahl R, Pedersen B. Influence of nedocromil solution on the dual asthmatic reaction after allergen challenge: A double-blind, placebo-controlled study. Eur J Resp Dis 1986; 69: 263–265, (Suppl. 147)
   Google Scholar
• Leung K BP, Fline K C., Brostaff J, Hudspith B N., Johnson N M., Pearce F L. A comparison of nedocromil sodium and sodium cromoglycate on human lung mast cell obtained by bronchoalveolar lavage and by dispersion of lung fragment. Eur J Resp Dis 1986; 96: 223, 226
   Google Scholar
• Holgate S T. Clinical evaluation of nedocromil sodium in asthma. Eur J Resp Dis 1986; 69: 149–159, (Suppl 147)
   Google Scholar
• Marks M B. Viewpoint: Theophylline: Primary or tertiary drug?. A brief review
   Google Scholar
• Newhouse M T., Dolovich M B. Current concepts: Control of asthma by aerosols. N Engl J Med 1986; 325: 870
   Google Scholar
• Baker M D. Theophylline toxicity in children. J Pediatr 1986; 209: 538
   Google Scholar
• Pauwels R. New aspects of the therapeutic potential of theophylline in asthma. J Allergy Clin Immunol 1989; 83: 548, 553
   PubMed Web of Science ®Google Scholar
• Smolensky M H., McGovern J, Scott P H., Reinberg A. Chronobiology and asthma. II. Body-time dependent differences in the kinetics and effects of the bronchodilator medications. J Asthma 1987; 24(2)91–134; 34–46
   PubMed Web of Science ®Google Scholar
• Smolensky M H., D'alonzo G. A J Med 1988; 88(1B)85
   Google Scholar
• Brown H, Storey G M., George W HS. Beclomethasone dipropionate; a new steroid aerosol for the treatment of allergic asthma. Br Med J 1972; 1: 585
   PubMed Web of Science ®Google Scholar
• Blackwell G J., Cornuccio R, DiRosa M, Flower R J., Parente L, Persico P. Macrocortin: Polypeptide causing the antiphospholipase effect of glucocorticoids. Nature 1980; 287: 147, 149
   PubMed Web of Science ®Google Scholar
• Hirata F, Axelrod J. Phospholipid methylation and biological signal transmission. Science 1980; 209: 1082, 1090
   PubMed Web of Science ®Google Scholar
• Brown H, Storey G M., Jackson F A. Beclomethasone diproprionate aerosol in long-term treatment of perennial and seasonal asthma in children and adults: a report of five and a half years experience in 600 asthmatic patients. Br J Clin Pharmacol 1977; 4: 2595
   Web of Science ®Google Scholar
• Toogood J H., Lefcoe N M., Haines D SM, Jennings B, Errington N, Chuang L. A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol 1977; 59: 298
   PubMed Web of Science ®Google Scholar
• Ryrfeldt A, Andersson P, Edsbacker S, Tonnesson M, Davies D, Pauwels R. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Research and Development Laboratories. AB Draco, Lund, Sweden, Royal Postgraduate Medical School, LondonEngland
   Google Scholar
• MacDonald G F., Knight A, Fleetham J, Sproule B, Dales R. A comparison of budesonide and placebo in oral-steroid-dependent asthmatics, a preliminary analysis. Glucocorticoids and Mechanisms of Asthma, F E. Hargreave, J. C. Hogg, J. L. Malo, J. H. Toogood, 1989; 111–124
   Google Scholar